“…A trifluoroanalogue of DCAC (trifluoroacylchloride) has been shown to acylate proteins, producing antigens involved in halothane-induced hepatitis Phol et al, 1991;Kenna et al, 1993;Chrsiten et al, 1994) and also, 2,2-dichlorotrifluoroethane-related liver disease (Hoet et al, 1997;White et al 2001). Similarly, covalent binding of TCE in vivo has been observed in rodents Bolt and Filser, 1977;Stot et al, 1982;Mazzullo et al, 1992;Stevens et al, 1992;Kautiainen et al, 1997). TCE-oxide and DCAC can covalently modify proteins directly to form protein adducts (Bloemen et al, 2001;Halmes et al, 1996Halmes et al, , 1997.…”